• Fenofibrate and Aging: Interpreting Liver Growth

  2026-09-25

  Fenofibrate is a PPARα agonist used to investigate lipid regulation and liver growth. This article examines what comparable responses in adult and aging mice mean for experimental design, pathway interpretation, and the limits of translating liver findings across research fields.

• L-Ornithine Workflows for Liver–Brain Metabolism

  2026-09-25

  Use L-Ornithine to distinguish substrate-driven effects from impaired OTC activity in urea-cycle and astrocyte experiments. A practical workflow connects metabolite measurements with glycolytic readouts while keeping proposed assay conditions separate from findings reported in the reference study.

• YC-1 Workflows for HIF-1α and Tumor Biology

  2026-09-24

  Use YC-1 to test whether hypoxia-linked HIF-1α signaling contributes to angiogenesis or cell-death phenotypes, with matched vehicle controls and orthogonal readouts. A recent mouse study also illustrates how YC-1 can serve as a pathway probe—while highlighting why results from neural tissue should not be treated as proof of tumor efficacy.

• Brefeldin A: Linking Trafficking Block to ER Stress

  2026-09-24

  Brefeldin A (BFA) is more than a vesicle transport inhibitor: it can help researchers distinguish disrupted protein trafficking from the ER stress response that follows. This article connects BFA-based experimental design with findings on UBR1 and UBR2, while clarifying what those findings do—and do not—say about BFA.

• hiPSC Intestinal Organoids for Pharmacokinetic Studies

  2026-09-23

  Saito and colleagues describe a direct 3D cluster-culture approach for generating expandable intestinal organoids from human pluripotent stem cells. The resulting organoids retain differentiation capacity and can produce intestinal epithelial cells with drug-metabolizing enzyme and transporter activity, offering a human-relevant platform for in vitro pharmacokinetic studies.

• Irisin Protects Mitochondria After Renal I/R Injury

  2026-09-23

  Cui and colleagues show that irisin, a skeletal-muscle-derived myokine, reduces renal ischemia–reperfusion injury while preserving mitochondrial quality-control responses in tubular epithelial cells. The study connects a systemic exercise-related signal with kidney mitochondrial biology and provides a framework for combining renal injury markers, live-tissue imaging, and mitophagy measurements in oxidative stress research.

• Dronedarone (Multaq) in AF Research

  2026-09-22

  Build exposure-matched atrial fibrillation workflows with Dronedarone (Multaq), from solvent preparation to automated whole-cell patch clamp. The approach distinguishes broad antiarrhythmic pharmacology from clinically relevant KCa2-channel activity, helping researchers avoid false mechanistic conclusions.

• Malate as a Flux Control in Tumor Immunometabolism

  2026-09-22

  Malate is more than a tricarboxylic acid cycle intermediate: it is a practical control for studying mitochondrial redox, metabolic flux, and immune consequences. This article explains how to use malate to interpret PDHA1-linked findings in cholangiocarcinoma without confusing a metabolic probe with a direct immune target.

• Cinoxacin: A UTI Research Assay Framework

  2026-09-21

  Cinoxacin is a quinolone antibiotic with a distinctive value in urinary tract infection research: it can connect concentration–response testing with clinically meaningful exposure and infection endpoints. This article develops a rigorous assay framework grounded in product specifications and insights from a phase 3 immunology trial.

• Brefeldin A (BFA): Reliable Cell Assays

  2026-09-21

  A scenario-driven guide to using Brefeldin A (SKU B1400) in viability, proliferation, cytotoxicity, trafficking, and ER-stress workflows. It explains dose selection, solvent and storage controls, assay compatibility, data interpretation, and practical criteria for selecting a dependable research reagent.

• DHHC9–STRN4 Palmitoylation Drives YAP Metastasis

  2026-09-20

  The reference study identifies a DHHC9–STRN4 palmitoylation mechanism that activates YAP and promotes adenocarcinoma cell migration and metastasis. Its combination of genetic, proteomic, functional, and pharmacological evidence positions DHHC9 as a candidate therapeutic target while highlighting the need for stronger selectivity and translational validation.

• Cyclic Pifithrin-α Hydrobromide Assay Design

  2026-09-19

  Cyclic Pifithrin-α hydrobromide is a p53 inhibitor for dissecting stress-induced apoptosis, growth arrest, and DNA-damage signaling. This guide connects its established pharmacology with the CGRP/SP–Piezo2 neuroinflammatory axis while defining practical controls and translational limits.

• 4-Hydroxytamoxifen: Practical Protocol and QC Guide

  2026-09-18

  4-Hydroxytamoxifen (SKU B6167) provides a DMSO-compatible estrogen receptor modulator for controlled in vitro workflows, including breast cancer research, prostate cancer research, apoptosis assays, and cardiac myocyte calcium handling studies. It should not be selected for protocols requiring water- or ethanol-based solubilization, and long-term storage of prepared solutions should be avoided.

• Alfuzosin HCl: Gastroretentive Research Workflows

  2026-09-18

  Build reproducible Alfuzosin HCl assays around receptor pharmacology, smooth-muscle models, and gastroretentive formulation testing. This guide translates a peer-reviewed sponge-delivery study into practical preparation, release-testing, imaging, and troubleshooting workflows for benign prostatic hyperplasia research.

• PQQ–Nrf2–IGF1R Axis in Age-Related Osteoarthritis

  2026-09-17

  This reference study identifies a PQQ–Nrf2–IGF1R pathway that links antioxidant defense to cartilage matrix maintenance in age-related osteoarthritis. Its combination of long-term mouse intervention, inflammatory chondrocyte models, tissue analysis, and loss-of-function experiments provides a mechanistic framework for studying oxidative stress and senescence in joint degeneration.

7822 records 1/522 page Next 12345 下5页 Last page